Back to discover
Disease

Asymptomatic Infections

Clinical development underwayEmerging researchCooling momentum
9
Publications
2
Clinical trials
3
Related conditions
3
Related proteins
2023
Latest publication
Current focus
Immunoglobulin g biologyTherapeutic developmentGenetics & risk factorsInflammation & immunity
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review.

Research2020-12-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.

Research2020-03-01Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
2
All trials
0
Active
0
Late-stage
1
Completed

Research activity

9 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20202023
Most influential
Major themes8
  • Coronavirus Infections3
  • Pandemics3
  • Pneumonia, Viral3
  • Asymptomatic Infections1
  • Betacoronavirus1
  • Contact Tracing1
  • Disease Transmission, Infectious1
  • Loss of Function Mutation1
Leading journals6
  • Science (New York, N.Y.)2
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin1
  • JAMA internal medicine1
  • Nature1
  • Nature medicine1
Leading researchers8
  • Abel L2
  • Bastard P2
  • Bettini LR2
  • Béziat V2
  • Bigio B2
  • Bilguvar K2
  • Biondi A2
  • Bizien L2
Affiliations (unnormalised)6
  • Imperial College London3
  • Aarhus University2
  • Aarhus University Hospital2
  • Centre for Primary Immunodeficiency Ghent (CPIG)2
  • Howard Hughes Medical Institute2
  • Institut Pasteur2

Disease biology

3 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

3 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Asymptomatic infections are infections that are present in the body but do not produce observable symptoms. The grounding also indicates that some infections can exist in a latent or subclinical state, with pathogen presence fluctuating below clinical detection.

Causes

The grounding does not support a specific aetiology for asymptomatic infections as a disease category. It does indicate that asymptomatic infection can occur with viral infections such as SARS-CoV-2 and human papillomavirus, but not a general cause beyond infection itself.

Pathophysiology

The literature grounding suggests that asymptomatic infection may involve latent or subclinical persistence of a pathogen with restricted gene expression and host immune control. Host immune surveillance and immune evasion are implicated in maintaining infection without symptoms, and molecular evolution is also a co-studied mechanism.

Risk factors

The grounding does not provide general risk factors for asymptomatic infections. It does indicate that host immune surveillance status is relevant in maintaining asymptomatic HPV infection, but no broader risk factors are supported.

Current standard of care

The grounding does not support a standard treatment for asymptomatic infections as a general category. The cited literature focuses on epidemiology, immune control, latency, and treatment methods for specific infections rather than a unified management approach for asymptomatic infection.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Infections that do not exhibit symptoms.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.